and being developed by Merck Co Inc and Ridgeback Biotherapeutics LP, is seen in this undated

Ridgeback Biotherapeutics said in a statement.... " Merck plans to seek emergency use authorisation in

with Ridgeback Biotherapeutics LP, the pill works by interfering with the virus’ replication. This

Москва. 28 января.

Государственный научный центр ？Институт иммунологии？ Федерального медико-биологического агентства (ФМБА) подал в Минздрав России документы на регистрацию препарата для лечения коронавируса ？Мир-19？, сообщает ТАСС. Фото: РИА Новости РИА Новости Препарат предназначен для профилактики и

Москва. 27 декабря.

Москва. 26 января.

Laboratory studies show that Merck Co's experimental oral COVID-19 antiviral drug, molnupiravir, is likely to be effective against known variants of the coronavirus, including the dominant, highly transmissible Delta, the company said on Wednesday. Since molnupiravir does not target the spike protein of the virus-the target of all current COVID-19 vaccines-which defines the differences between the variants, the drug should be equally effective as the virus continues to evolve, said Jay Grobler,

GENEVA--A U.N.-backed organization announced Thursday that it has signed agreements with more than two dozen generic drug makers to produce versions of Merck's COVID-19 pill to supply 105 developing countries. The Medicines Patent Pool said the deals would allow drug companies to make both the raw ingredients for molnupiravir and the finished product itself. Molnupiravir, developed by Merck and Ridgeback Therapeutics, has been reported to cut the hospitalization rate in half among patients with

( Reuters)-U.S. drugmaker Merck Co Inc said on Monday the European Union's drug regulator has initiated a real-time review of its experimental COVID-19 antiviral drug for adults. Under the procedure, also known as a" rolling review", the European Medicines Agency( EMA) would assess data as soon as it becomes available, instead of waiting for a formal application when all required information has been gathered. While vaccines are the main weapons against COVID-19, Merck's experimental pill molnup